Trulieve Cannabis Corp (TCNNF)
6.80
+0.23
(+3.50%)
USD |
OTCM |
Nov 15, 16:00
Trulieve Cannabis Gross Profit Margin (Quarterly): 60.95% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 60.95% |
| June 30, 2024 | 59.86% |
| March 31, 2024 | 58.40% |
| December 31, 2023 | 53.61% |
| September 30, 2023 | 51.94% |
| June 30, 2023 | 50.26% |
| March 31, 2023 | 52.66% |
| December 31, 2022 | 52.64% |
| September 30, 2022 | 57.12% |
| June 30, 2022 | 58.43% |
| March 31, 2022 | 56.79% |
| December 31, 2021 | 44.46% |
| Date | Value |
|---|---|
| September 30, 2021 | 68.70% |
| June 30, 2021 | 67.16% |
| March 31, 2021 | 69.79% |
| December 31, 2020 | 71.17% |
| September 30, 2020 | 74.98% |
| June 30, 2020 | 74.97% |
| March 31, 2020 | 76.86% |
| December 31, 2019 | -78.05% |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | 90.19% |
| December 31, 2018 | 23.96% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-78.05%
Minimum
Dec 2019
76.86%
Maximum
Mar 2020
54.14%
Average
58.41%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Bruker Corp | 48.45% |
| Karyopharm Therapeutics Inc | 96.65% |
| Apellis Pharmaceuticals Inc | 82.95% |
| cbdMD Inc | 65.78% |
| Flora Growth Corp | 20.19% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -9.30% |
| Return on Assets | -4.58% |
| Return on Invested Capital | -6.82% |
| Profit Margin (Quarterly) | -21.18% |
| Operating Margin (Quarterly) | -1.29% |
| Return on Net Operating Assets | -5.20% |